nvt
Conditions
Interventions
None listed
Sponsors
Endocrinologie
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: >18 years with osteoporosis, osteopenia, with and without fractures or normal bone mass with fractures or metabolic bone diseases
Exclusion criteria
Exclusion criteria: * Active infection of the measurement site. * Recent fracture of the tibia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main study parameters/endpoints: Compare the validity of microindentation measurements with that of BMD measurements as predictor for bone strength as translated by prevalent fractures in the case of patients with osteoporosis | — |
Secondary
| Measure | Time frame |
|---|---|
| .to evaluate the ability of BMT measurements in patients treated with Bisphosphonates, particularly in the longterm, and to predict the role of local increasement in bone turnover in altering bone quality in localised bone diseases such as Paget disease of bone and fibrous dysplasia. | — |
Countries
Netherlands
Outcome results
None listed